| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10966263 | Vaccine | 2013 | 7 Pages |
Abstract
All three S. Typhi vectored pneumococcal vaccines were safe and well-tolerated. Immunogenicity was limited possibly due to pre-existing high antibody titers prior to vaccination. Increases in IgA were most often observed.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Sharon E. Frey, Kathleen R. Lottenbach, Heather Hill, Tamara P. Blevins, Yinyi Yu, Ying Zhang, Karen E. Brenneman, Sandra M. Kelly-Aehle, Caitlin McDonald, Angela Jansen, Roy 3rd,